Niagen Bioscience, Inc. Common Stock NAGE Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $18.64M+32.1% | $17.38M+103% | $20.43M+1,390% | $17.73M+1,309% | $14.11M+487% | ||
| $570K-11.4% | $612K-7.7% | $624K-9.4% | $631K-16.8% | $643K-21.6% | ||
| $6.71M+79.0% | $6.07M+65.9% | $5.07M+28.7% | $4.05M-6.3% | $3.75M-16.0% | ||
| $4.43M-77.8% | $13.5M+9.1% | $21.41M+382% | $21.21M+1,483% | $19.96M+332% | ||
| $4.99M+3,820% | -$292K-104% | -$260K-174% | -$257K-157% | -$134K-44.1% | ||
| —— | —— | —— | —— | $0— | ||
| $1.6M-81.1% | $7M+30.3% | $10.74M+595% | $11.64M+2,213% | $8.49M+8,341% | ||
| $10.93M-61.0% | $20.13M+16.1% | $31.89M+467% | $32.59M+2,103% | $28.05M+534% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Niagen Bioscience, Inc. Common Stock generate?
- Niagen Bioscience, Inc. Common Stock (NAGE) generated $4.4M in operating cash flow over the trailing twelve months.
- Where does Niagen Bioscience, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Niagen Bioscience, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
